세계의 나노바이오테크놀러지 시장 : 제품별, 용도별 예측(2025-2030년)

The Nanobiotechnology Market was valued at USD 3.49 billion in 2023, expected to reach USD 4.11 billion in 2024, and is projected to grow at a CAGR of 16.04%, to USD 9.91 billion by 2030.

Nanobiotechnology is a burgeoning field at the crossroads of nanotechnology and biotechnology, focusing on the manipulation and control of biological and non-biological systems at the molecular and atomic levels. Its scope encompasses various applications, from drug delivery systems and diagnostic tools to agricultural innovations and environmental remediation. The necessity for nanobiotechnology arises from its potential to revolutionize healthcare by enabling precise medical treatments, improving drug efficacy, and providing scalable solutions for numerous industries. In terms of application, it finds use in medical and pharmaceutical segments, targeting cancer therapy, regenerative medicine, and disease diagnostics. The end-use scope of nanobiotechnology also includes agriculture, where it contributes to smart delivery systems for nutrients and pesticides, and in environmental sectors, addressing pollution through nanomaterials.

Market growth in nanobiotechnology is propelled by several factors, including advancements in nanoscale science and technology, increased R&D funding, and a rising prevalence of chronic diseases necessitating innovative treatments. Additionally, the growing demand for personalized medicine further fuels its development. However, market expansion is tempered by challenges such as high costs, ethical concerns, and regulatory issues associated with nanomaterials. Opportunities lie in forming strategic partnerships between biotech companies and research institutions to accelerate innovation. Furthermore, tapping into emerging markets, which exhibit a growing demand for advanced healthcare solutions, presents significant potential.

Investment in areas such as nanomedicine and nano-enabled diagnostics is advisable. Nanobiotechnology's greatest promise lies in its capacity to innovate drug delivery systems and develop precise diagnostic tools, which can translate into substantial business growth. Nevertheless, companies must navigate the regulatory landscape meticulously to ensure compliance and address safety concerns. This dynamic market demands continuous innovation and adaptation, with successful firms poised to spearhead advancements in biotechnology while simultaneously benefitting from collaborative ventures and strategic alliances. Emphasizing research into sustainable nanomaterials could also position companies advantageously amid increasing environmental consciousness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nanobiotechnology Market

The Nanobiotechnology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing the use of nanobiotechnology for improving healthcare practices
  • Rising drug discovery and development processes
  • Utilization of nanotechnology for development of sustainable biomaterials
• Market Restraints
  • Ethical and environmental issues associated with nanobiotechnology
• Market Opportunities
  • Increasing research in genomics and proteomics
  • Emerging use of nanobiotechnology in agriculture
• Market Challenges
  • Regulations governing nanotechnology products

Porter's Five Forces: A Strategic Tool for Navigating the Nanobiotechnology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nanobiotechnology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nanobiotechnology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nanobiotechnology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nanobiotechnology Market

A detailed market share analysis in the Nanobiotechnology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nanobiotechnology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nanobiotechnology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nanobiotechnology Market

A strategic analysis of the Nanobiotechnology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nanobiotechnology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Analog Devices, Inc., ANSELL LTD., Arkema S.A., Bruker Corporation, DuPont de Nemours, Inc., Eurofins Scientific SE, Evonik Industries AG, Honeywell International Inc., Merck KGaA, Nanoscience Instruments, Inc., Nanospan Inc., Sioen Industries NV, Texas Instruments Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nanobiotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Nano-Enabled Drugs, Nanodevices, Nanoparticles, and Nanotechnology Tools.
• Based on Application, market is studied across Agriculture, Cancer Treatment, Diagnostics, Drug Delivery, Environmental Monitoring, Regenerative Medicines, and Therapeutics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing the use of nanobiotechnology for improving healthcare practices
    • 5.1.1.2. Rising drug discovery and development processes
    • 5.1.1.3. Utilization of nanotechnology for development of sustainable biomaterials
  • 5.1.2. Restraints
    • 5.1.2.1. Ethical and environmental issues associated with nanobiotechnology
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing research in genomics and proteomics
    • 5.1.3.2. Emerging use of nanobiotechnology in agriculture
  • 5.1.4. Challenges
    • 5.1.4.1. Regulations governing nanotechnology products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nanobiotechnology Market, by Product

• 6.1. Introduction
• 6.2. Nano-Enabled Drugs
• 6.3. Nanodevices
• 6.4. Nanoparticles
• 6.5. Nanotechnology Tools

7. Nanobiotechnology Market, by Application

• 7.1. Introduction
• 7.2. Agriculture
• 7.3. Cancer Treatment
• 7.4. Diagnostics
• 7.5. Drug Delivery
• 7.6. Environmental Monitoring
• 7.7. Regenerative Medicines
• 7.8. Therapeutics

8. Americas Nanobiotechnology Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Nanobiotechnology Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Nanobiotechnology Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Agilent Technologies, Inc.
• 3. Analog Devices, Inc.
• 4. ANSELL LTD.
• 5. Arkema S.A.
• 6. Bruker Corporation
• 7. DuPont de Nemours, Inc.
• 8. Eurofins Scientific SE
• 9. Evonik Industries AG
• 10. Honeywell International Inc.
• 11. Merck KGaA
• 12. Nanoscience Instruments, Inc.
• 13. Nanospan Inc.
• 14. Sioen Industries NV
• 15. Texas Instruments Incorporated
• 16. Thermo Fisher Scientific Inc.